reference/12578353

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12578353

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	513
issn	0344-5704 1432-0843
issueIdentifier	6
pageRange	505-513
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	505
bibliographicCitation	Kano Y, Akutsu M, Tsunoda S, Izumi T, Mori K, Fujii H, Yazawa Y, Mano H, Furukawa Y. Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro. Cancer Chemother Pharmacol. 2004 Dec;54(6):505–13. doi: 10.1007/s00280-004-0839-5. PMID: 15340759.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c56c0d7e4bb07c2b9afdc2ac72579fd4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee87751b751ba9fb90c6c98b2b89e01f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc1c7047bee25afa9a88f70b9fc3b4dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1cca967038bd80a097d6f458abec439 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_682ceb1c3416632a4c82a0e515573be2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaae3f196f0fc56040a80cc7c2461a04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ea3a859f49a8064edada0e6dbe1c201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_938a8e9e153396c4dc4886b94f8680ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_298b53da1bc09feef3b02d3762f7b3c7
date	2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15340759 https://doi.org/10.1007/s00280-004-0839-5
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664 https://portal.issn.org/resource/ISSN/0344-5704 https://portal.issn.org/resource/ISSN/1432-0843
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro
discusses	http://id.nlm.nih.gov/mesh/M0008662 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0009376
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D006147Q000494 http://id.nlm.nih.gov/mesh/D017239Q000494 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D005971Q000494 http://id.nlm.nih.gov/mesh/D000971Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D005493Q000494 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D002455Q000187 http://id.nlm.nih.gov/mesh/D005493Q000008 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004347 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D004334
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_980a8f4f8b386a83ddbdd6ef81f1db24 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c528886611d583e4386f60bdfd94dd17 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026

Total number of triples: 65.